UBS Keeps Boston Scientific at Buy, Cuts Price Target to $57
UBS lowered its price target from $67 to $57, a 14.9% decrease. The new target implies 34.3% upside from the Oct. 28 close of $42.43.
Story updates
06:35:23 PM UTC
SquawkNews
Boston Scientific Price Target Cut to $57.00/Share From $67.00 by UBS